Skip to main content

Dacarbazine Injection

Last Updated: February 6, 2023
Status: Current

Products Affected - Description
    • Dacarbazine lyophilized powder for injection, Fresenius Kabi, 200 mg, vial, 1 count, NDC 63323-0128-20
    • Dacarbazine lyophilized powder for injection, Teva, 200 mg, vial, 1 count, NDC 00703-5075-01
    • Dacarbazine lyophilized powder for injection, Teva, 200 mg, vial, 10 count, NDC 00703-5075-03
Reason for the Shortage
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma has dacarbazine injection available.
    • Teva has dacarbazine injection on shortage due to manufacturing delays.
Available Products
    • Dacarbazine lyophilized powder for injection, Fresenius Kabi, 100 mg, vial, 1 count, NDC 63323-0127-10
    • Dacarbazine lyophilized powder for injection, Hikma, 200 mg, vial, 1 count, NDC 55390-0090-10

Estimated Resupply Dates

    • Fresenius Kabi has dacarbazine 200 mg vials on back order and the company estimates a release date of early-February 2023.
    • Teva has dacarbazine 200 mg vials in 1 count and 10 count temporarily unavailable and the company cannot estimate a release date.

Updated

Updated February 6, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 23, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer